Tag
Tag: Janssen
Update: First Ever Ebola Vaccine Gets US and EU Approval
European Project Launches to Tailor Autoimmune Disease Treatments
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
More News! Multiple sclerosis, breast milk killing tumors, glucose-sensing tattoos and more…
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma
Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease
Llama Antibodies Could Be the Key to Universal Flu Prevention
A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains
